BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 939 found
  Current Search:  hpv: 939     

HTML
100%
Starpharma Holdings Limited SPL7013 Shows Activity Against All Major Clinically Relevant Human Papillomavirus
(ABN Newswire) - Starpharma Holdings Ltd (ASX:SPL)(OTCQX:SPHRY) today announced new data showing that SPL7013, the active ingredient in its topical microbicide VivaGel(R), inhibits all four strains of the human papillomavirus (HPV)...
Pharma Live:  Dec 5 2008 9:35AM
Matching: hpv
Find similar documents
HTML
100%
Starpharma Holdings LtdEURs SPL7013 Shows Activity Against All Major Clinically Relevant Human Papillomaviru
: (ASX:SPL, OTCQX:SPHRY) today announced new data showing that SPL7013, the active ingredient in its topical microbicide VivaGel, inhibits all four strains of the human papillomavirus (HPV) targeted by the two marketed cervical cancer...
BioSpace:  Dec 5 2008 7:13AM
Matching: hpv
Find similar documents
HTML
100%
Genetic Breakdown In Fanconi Anemia May Have Link To HPV-Associated Cancer
Cervical Cancer / HPV Vaccine News Main Category: Cervical Cancer / HPV Vaccine Also Included In: Genetics; Blood / Hematology email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient...
Medical News Today:  Dec 5 2008 12:12AM
Matching: hpv
Find similar documents
HTML
100%
GlaxoSmithKline To Reduce Price Of HPV Vaccine Cervarix In South Africa
Cervical Cancer / HPV Vaccine News Main Category: Cervical Cancer / HPV Vaccine Also Included In: Pharma Industry / Biotech Industry email to a friend printer friendly view / write opinions rate article Current Article Ratings:...
Medical News Today:  Dec 5 2008 12:18PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

HealthScout:  Dec 5 2008 9:33AM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

Marshall News Messenger:  Dec 5 2008 9:29AM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

Health Day:  Dec 5 2008 7:07AM
Matching: hpv
Find similar documents
HTML
100%
Merck 2009 Earnings, Revenue Guidance Trails Wall Street Estimates
MRK Headline Feed Sector Feeds: Pharma major Merck & Co.

(NYSE: MRK) said its earnings and revenue will fall below Wall Street estimates.

Excluding one-time items the company now expects to post earnings in the range of $3.15 to ...

I Stock Analyst:  Dec 5 2008 9:38AM
Matching: hpv
Find similar documents
HTML
100%
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Se
Biotech, Roundup, ZymoGenetics Luke Timmerman 12/4/08 The big news of the past couple weeks came before Thanksgiving, when one of Seattles biotech pioneers, Bruce Carter, decided to exit stage left.

Here is that and other highlights of the...

Xconomy:  Dec 5 2008 2:39AM
Matching: hpv
Find similar documents
HTML
100%
Starpharma Holdings Limited (ASX:SPL) SPL7013 Shows Activity Against All Major Clinically Relevant Human Papil
Also News Release (U-ARLTF) ADAMUS RESOURCES LTDAlso News Release (U-BHP) BHP BILLITON LTDAlso News Release (U-CSBR) CHAMPIONS BIOTECHNOLOGY INCAlso News Release (U-RTOLY) RIO TINTO LTD ADRAlso News Release (U-SPHRY) Melbourne, Australia,...
Stockwatch:  Dec 4 2008 3:45AM
Matching: hpv
Find similar documents
HTML
100%
Genetic Breakdown In Fanconi Anemia May Have Link To HPV-associated Cancer
ScienceDaily (Dec.

3, 2008) A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to...

Science Daily:  Dec 4 2008 8:40PM
Matching: hpv
Find similar documents
HTML
100%
Genetic Breakdown In Fanconi Anemia Linked To HPV-Associated Cancer
Cincinnati Children's study shows possible new cancer risk and path to testing treatments A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell...
Red Orbit:  Dec 4 2008 4:04AM
Matching: hpv
Find similar documents
HTML
100%
The Pros (and Not Many Cons) of Mercks HPV Vaccine, According to UWs Laura Koutsky
Biotech, vaccines, Gardasil Luke Timmerman 12/3/08 Everyone has human papillomavirus (HPV) crawling all over our skin.

This usually doesnt cause us any harm, but in about 11,000 cases a year in the U.S., sexual activity leads to an...

Xconomy:  Dec 4 2008 1:01AM
Matching: hpv
Find similar documents
HTML
100%
Hypersensitivity Reactions to the Quadrivalent HPV Vaccine Are Rare
Newswise Hypersensitivity reactions to the quadrivalent HPV vaccine (4vHPV, Gardasil) are uncommon and most schoolgirls can tolerate subsequent doses, finds the first evaluation of the quadrivalent HPV vaccine published on bmj...
Newswise:  Dec 4 2008 1:31PM
Matching: hpv
Find similar documents
HTML
100%
Hypersensitivity Reactions To The Quadrivalent HPV Vaccine Are Rare, British Medical Journal
Hypersensitivity reactions to the quadrivalent HPV vaccine (4vHPV, Gardasil) are uncommon and most schoolgirls can tolerate subsequent doses, finds the first evaluation of the quadrivalent HPV vaccine published on today.

In...

Medical News Today:  Dec 4 2008 11:41AM
Matching: hpv
Find similar documents
HTML
100%
A step ahead for cervical cancer vaccines
Australia-based Starpharmas-SPL7013, inhibits all four strains of the human papillomavirus (HPV) targeted by the two marketed cervical cancer vaccines.

This is the active ingredient in the companys topical microbicide, VivaGel.

Bio Spectrum Asia:  Dec 4 2008 9:42AM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer - New data from P.S.D. Souza et al illuminate research in cervical cancer
According to a study from Sao Paulo, Brazil, 'Persistent infection with oncogenic types of (HPV) is the major for (ICC), and non-European variants of HPV-16 are associated with an increased risk of persistence and ICC.
NewsRX:  Dec 4 2008 4:27AM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

National Womens Health Information Center:  Dec 4 2008 10:17PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
Reactions such as hives called 'idiosyncratic,' study finds -- Robert Preidt THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses....

MSN:  Dec 4 2008 9:03PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

Washington Post:  Dec 4 2008 8:15PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
Reactions such as hives called 'idiosyncratic,' study finds THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the...

Forbes.com:  Dec 4 2008 7:30PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

Springfield News Sun:  Dec 4 2008 7:04PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

Medbroadcast:  Dec 4 2008 6:30PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated
THURSDAY, Dec.

4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after...

Grand Junction Daily Sentinel:  Dec 4 2008 5:52PM
Matching: hpv
Find similar documents
HTML
100%
Cervical Cancer Vaccine Well Tolerated (HealthDay)
Play Video Video: Young Chef Battling Cancer Shows Off Skills CBS 2 / KCAL 9 Los Angeles Play Video Video: Ailing Bucks Co.

Grandmother Has Last Wish Granted CBS 3 Philadelphia Play Video Video: Radiation Therapy Reduces The Chances Of...

Yahoo!:  Dec 4 2008 5:13PM
Matching: hpv
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.